Rapidly progressive interstitial lung disease associated with dermatomyositis responding to intravenous cyclophosphamide pulse therapy

Internal Medicine

Volumn 36, Issue 7, 1997, Pages 519-523

  Shinohara, Tadashi ^a   Hidaka, Toshihiko ^a   Matsuki, Yasunori ^a   Ishizuka, Toshiaki ^a   Takamizawa, Mitsuyo ^a   Kawakami, Makoto ^a   Kikuma, Hideki ^a   Suzuki, Kimihiro ^a   Nakamura, Haruo ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Bronchiolitis obliterans organizing pneumonia (BOOP); Immunosuppressant

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BRONCHIOLITIS; CASE REPORT; CORTICOSTEROID THERAPY; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL LUNG DISEASE; INTRAVENOUS DRUG ADMINISTRATION; LUNG BIOPSY; ORAL DRUG ADMINISTRATION; POLYMYOSITIS; RESPIRATORY DISTRESS;

EID: 0030793559     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.36.519     Document Type: Article

References (24)

1. Lakhanpal S, Lie JT, Conn DL, Martin WJ. Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis 46: 23, 1987.
2. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 141: 727, 1990.
3. Guerry-Force ML, Muller NL, Wright JL, et al. A comparison of bronchiolitis obliterans with organizing pneumonia, usual interstitial pneumonia, and small airways disease. Am Rev Respir Dis 135: 705, 1987.
4. Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 18: 136, 1994.
5. Austin HA, Klippel JH, Balow JE, et al. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314: 614, 1986.
6. Balow JE, Austin HA, Tsokos GC, Antonovych TT, Steinberg AD, Klippel JH. NIH conference. Lupus nephritis. Ann Intern Med 106: 79, 1987.
7. McCune WJ, Golbus J, Zeldes W, Bohlke P, Dunne R, Fox DA. Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. N Engl J Med 318: 1423, 1988.
8. al-Janadi M, Smith CD, Karsh J. Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis. J Rheumatol 16: 1592, 1989 (see comments).
9. Boumpas DT, Austin HA, Vaughn EM, et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 340: 741, 1992.
10. Tanimoto K, Nakano K, Kano S, et al. Classification criteria for polymyositis and dermatomyositis. J Rheumatol 22: 668, 1995 (see comments, published erratum appears in J Rheumatol 22: 1807, 1995).
11. Tanimoto K, Nakano K, Kano S, et al. Classification criteria for polymyositis and dermatomyositis. J Rheumatol 22: 668, 1995 (see comments, published erratum appears in J Rheumatol 22: 1807, 1995).
12. Bensard DD, McIntyre RC Jr, Waring BJ, Simon JS. Comparison of video thoracoscopic lung biopsy to open lung biopsy in the diagnosis of interstilial lung disease. Chest 103: 765, 1993.
13. Yousem SA, Colby TV, Carrington CB. Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis 131: 770, 1985.
14. Baughman RP, Lower EE. Use of intermittent, intravenous cyclophosphamide for idiopathic pulmonary fibrosis. Chest 102: 1090, 1992.
15. du Bois RM. Idiopathic pulmonary fibrosis. Annu Rev Med 44: 441, 1993.
16. Marinelli WA. Idiopathic pulmonary fibrosis. Progress and challenge. Chest 108: 297, 1995 (editorial; comment).
17. Cordier JF, Loire R, Brune J. Idiopathic bronchiolitis obliterans organizing pneumonia. Definition of characteristic clinical profiles in a series of 16 patients. Chest 96: 999, 1989.
18. Chandler PW, Shin MS, Friedman SE, Myers JL, Katzenstein AL. Radiographic manifestations of bronchiolitis obliterans with organizing pneumonia vs usual interstitial pneumonia. AJR Am J Roentgenol 147: 899, 1986.
19. Gruhn WB, Diaz-Buxo JA. Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomyositis/polymyositis. J Rheumatol 14: 1045, 1987.
20. Pugh MT, Collins NA, Rai A, Hollinrake K, Coppock JS. A case of adult dermatomyositis treated with cyclosporin A. Br J Rheumatol 31: 855, 1992 (letter).
21. Soga T, Hagiwara E, Shirai A, Igarashi T, Ishigatsubo Y, Okubo T. Successful therapy with cyclosporine in a case with interstitial pneumonitis associated with polymyositis. Nihon Rinsho Meneki Gakkai Kaishi 19: 157, 1996.
22. Dickey BF, Myers AR. Pulmonary disease in polymyositis/dermatomyositis. Semin Arthritis Rheum 14: 60, 1984.
23. Takizawa H, Shiga J, Moroi Y, Miyachi S, Nishiwaki M, Miyamoto T. Interstitial lung disease in dermatomyositis: clinicopathological study. J Rheumatol 14: 102, 1987.
24. Arsura EL, Greenberg AS. Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis. Semin Arthritis Rheum 18: 29, 1988.